Clinical Trial Update: Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PF-06947386 for efficacy and safety in Japanese adults with complicated intra-abdominal infection has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• PF-06947386

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-abdominal Infection | Phase 3 | Status: COMPLETED | Results posted: 2024-03-08